Journal article Open Access

Molecular targets for AIDS therapy

Mitsuya, H.; Yarchoan, R.; Broder, S.


JSON-LD (schema.org) Export

{
  "description": "The development of antiretroviral therapy against acquired immunodeficiency syndrome (AIDS) has been an intense research effort since the discovery of the causative agent, human immunodeficiency virus (HIV). A large array of drugs and biologic substances can inhibit HIV replication in vitro. Nucleoside analogs--particularly those belonging to the dideoxynucleoside family--can inhibit reverse transcriptase after anabolic phosphorylation. 3'-Azido-2',3'-dideoxythymidine (AZT) was the first such drug tested in individuals with AIDS, and considerable knowledge of structure-activity relations has emerged for this class of drugs. However, virtually every step in the replication of HIV could serve as a target for a new therapeutic intervention. In the future, non-nucleoside-type drugs will likely become more important in the experimental therapy of AIDS, and antiretroviral therapy will exert major effects against the morbidity and mortality caused by HIV.", 
  "license": "https://creativecommons.org/publicdomain/zero/1.0/legalcode", 
  "creator": [
    {
      "@type": "Person", 
      "name": "Mitsuya, H."
    }, 
    {
      "@type": "Person", 
      "name": "Yarchoan, R."
    }, 
    {
      "@type": "Person", 
      "name": "Broder, S."
    }
  ], 
  "headline": "Molecular targets for AIDS therapy", 
  "image": "https://zenodo.org/static/img/logos/zenodo-gradient-round.svg", 
  "datePublished": "1990-09-28", 
  "url": "https://zenodo.org/record/1230944", 
  "@context": "https://schema.org/", 
  "identifier": "https://doi.org/10.1126/science.1699273", 
  "@id": "https://doi.org/10.1126/science.1699273", 
  "@type": "ScholarlyArticle", 
  "name": "Molecular targets for AIDS therapy"
}
482
291
views
downloads
Views 482
Downloads 291
Data volume 887.0 MB
Unique views 460
Unique downloads 276

Share

Cite as